The anti-metastatic effect of baicalein on colorectal cancer

Oncology Reports

Volumn 37, Issue 4, 2017, Pages 2317-2323

  Chai, Yuxia ^a   Xu, Jizhong ^a   Yan, Baojun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Baicalein; Colorectal Cancer; ERK; Invasion And Migration; MMP

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BAICALEIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; 1,3 BUTADIENE DERIVATIVE; FLAVANONE DERIVATIVE; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; NITRILE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG STRUCTURE; GROWTH INHIBITION; HT-29 CELL LINE; HUMAN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT DURATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; CELL MOTION; COLORECTAL NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BUTADIENES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLAVANONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NITRILES; PHOSPHORYLATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85016426192     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2017.5437     Document Type: Article

References (33)

1. Ma YS, Hsiao YP, Lin JH, Hsu SC, Chueh FS, Weng SW, Lai KC, Lin JG and Chung JG: Crude extract of Rheum palmatum L inhibits migration and invasion of LS1034 human colon cancer cells acts through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling. Environ Toxicol 30: 852-863, 2014.
2. Patiutko IuI, Pylev AL, Sagaidak IV, Poliakov AN, Chuchuev ES, Abgarian MG and Shishkina NA: Surgical and combined treatment of patients with metastatic liver and lymph nodes invasion by colorectal cancer. Khirurgiia (Mosk) 7: 49-54, 2010 (in Russian).
3. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J and Li Z : Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS One 8: e72927, 2013.
4. G ialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278: 16-27, 2011.
5. Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, Shimada Y, Ari-i S, Wada H, Fujimoto J, et al: Constitutive activation of the 41-/43-kDa mitogen-Activated protein kinase signaling pathway in human tumors. Oncogene 18: 813-822, 1999.
6. Z hang H, Shen B, Swinarska JT, Li W, Xiao K and He P: 9-Hydroxypheophorbide α-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway. Photodiagn Photodyn Ther 11: 55-62, 2014.
7. Kress TR, Raabe T and Feller SM: High Erk activity suppresses expression of the cell cycle inhibitor p27Kip1 in colorectal cancer cells. Cell Commun Signal 8: 1, 2010.
8. Park KS, Lee NG, Lee KH, Seo JT and Choi KY: The ERK pathway involves positive and negative regulations of HT-29 colorectal cancer cell growth by extracellular zinc. Am J Physiol Gastrointest Liver Physiol 285: G1181-G1188, 2003.
9. Kim HC, Kim YS, Oh HW, Kim K, Oh SS, Kim JT, Kim BY, Lee SJ, Choe YK, Kim DH, et al: Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells. Oncotarget 5: 519-529, 2014.
10. Ai X, Wu Y, Zhang W, Zhang Z, Jin G, Zhao J, Yu J, Lin Y, Zhang W, Liang H, et al: Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer. Cancer Biol Ther 14: 1059-1067, 2013.
11. Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 297: 42-48, 2010.
12. Kim DH, Hossain MA, Kang YJ, Jang JY, Lee YJ, Im E, Yoon JH, Kim HS, Chung HY and Kim ND: Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int J Oncol 43: 1652-1658, 2013.
13. Chen J, Li Z, Chen AY, Ye X, Luo H, Rankin GO and Chen YC: Inhibitory effect of baicalin and baicalein on ovarian cancer cells. Int J Mol Sci 14: 6012-6025, 2013.
14. Li HL, Zhang S, Wang Y, Liang RR, Li J, An P, Wang ZM, Yang J and Li ZF: Baicalein induces apoptosis via a mitochondrialdependent caspase activation pathway in T24 bladder cancer cells. Mol Med Rep 7: 266-270, 2013.
15. Liang RR, Zhang S, Qi JA, Wang ZD, Li J, Liu PJ, Huang C, Le XF, Yang J and Li ZF: Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling. Int J Oncol 41: 969-978, 2012.
16. Z hang Z, Lv J, Lei X, Li S, Zhang Y, Meng L, Xue R and Li Z: Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. PLoS One 9: e90318, 2014.
17. Chandrashekar N, Selvamani A, Subramanian R, Pandi A and Thiruvengadam D: Baicalein inhibits pulmonary carcinogenesisassociated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo. Toxicol Appl Pharmacol 261: 10-21, 2012.
18. Wu B, Li J, Huang D, Wang W, Chen Y, Liao Y, Tang X, Xie H and Tang F: Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer 11: 527, 2011.
19. Wang ZD, Huang C, Li ZF, Yang J, Li BH, Liang RR, Dai ZJ and Liu ZW: Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep 23: 413-421, 2010.
20. Organ SL, Hai J, Radulovich N, Marshall CB, Leung L, Sasazuki T, Shirasawa S, Zhu CQ, Navab R, Ikura M, et al: p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line. PLoS One 9: e86103, 2014.
21. Laezza C, Caruso MG, Gentile T, Notarnicola M, Malfitano AM, Di Matola T, Messa C, Gazzerro P and Bifulco M: N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. Int J Cancer 124: 1322-1329, 2009.
22. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y and Nagawa H: Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63: 1706-1711, 2003.
23. Ibrahim A, Sobeh M, Ismail A, Alaa A, Sheashaa H, Sobh M and Badria F: Free-B-Ring flavonoids as potential lead compounds for colon cancer therapy. Mol Clin Oncol 2: 581-585, 2014.
24. Chiu YW, Lin TH, Huang WS, Teng CY, Liou YS, Kuo WH, Lin WL, Huang HI, Tung JN, Huang CY, et al: Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol Appl Pharmacol 255: 316-326, 2011.
25. Dziki L, Przybyłowska K, Majsterek I, Trzciński R, Mik M and Sygut A: A/G polymorphism of the MMP-7 gene promoter region in colorectal cancer. Pol Przegl Chir 83: 622-626, 2011.
26. Artym VV, Yamada KM and Mueller SC: ECM degradation assays for analyzing local cell invasion. Methods Mol Biol 522: 211-219, 2009.
27. Z hang Y, Liu H, Jin J, Zhu X, Lu L and Jiang H: The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anticancer Drugs 21: 494-501, 2010.
28. Cohen M, Meisser A, Haenggeli L and Bischof P: Involvement of MAPK pathway in TNF-Alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 12: 225-232, 2006.
29. Liu SQ, Huang JA, Qin MB, Su YJ, Lai MY, Jiang HX and Tang G D: Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Int J Colorectal Dis 27: 1569-1578, 2012.
30. Chen YY, Liu FC, Chou PY, Chien YC, Chang WS, Huang GJ, Wu CH and Sheu MJ: Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways. Evid Based Complement Alternat Med 2012: 378415, 2012.
31. Lin F, Chengyao X, Qingchang L, Qianze D, Enhua W and Yan W: CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway. Mol Carcinog 54 (Suppl 1): E35-E44, 2014.
32. Deng W, Sui H, Wang Q, He N, Duan C, Han L, Li Q, Lu M, and Lv S: A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways. BMC Complement Altern Med 13: 65, 2013.
33. Babykutty S, Suboj P, Srinivas P, Nair AS, Chandramohan K and Gopala S: Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways. Clin Exp Metastasis 29: 471-492, 2012.